EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
119 hedge funds and large institutions have $1.04B invested in Eagle Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $1.08B → $1.04B (-$39.8M)
31% less call options, than puts
Call options by funds: $7.06M | Put options by funds: $10.2M
Holders
119
Holding in Top 10
6
Calls
$7.06M
Puts
$10.2M
Top Buyers
| 1 | +$19.1M | |
| 2 | +$17.7M | |
| 3 | +$12.6M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.32M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$5.47M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$8.14M | |
| 3 | -$3.85M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.84M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$3.83M |